- Home
- MGN vs MODD Comparison
MGN vs MODD Comparison
Compare MGN & MODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MGN | MODD |
|---|---|---|
| Founded | 2020 | 1998 |
| Country | | |
| Employees | N/A | N/A |
| Industry | | Industrial Specialties |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.6M | 33.3M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | MGN | MODD |
|---|---|---|
| Price | $2.01 | $0.46 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 16.3K | ★ 184.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $32.33 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.30 | $0.28 |
| 52 Week High | $8.63 | $1.29 |
Technical Indicators
Market Signals| Indicator | MGN | MODD |
|---|---|---|
| Relative Strength Index (RSI) | 57.11 | 51.36 |
| Support Level | $1.77 | $0.43 |
| Resistance Level | $2.13 | $0.49 |
| Average True Range (ATR) | 0.16 | 0.04 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 72.65 | 43.77 |
Price Performance
Historical ComparisonAbout MGN Megan Holdings Limited Ordinary Shares
Megan Holdings Ltd is principally engaged in the development, construction and maintenance of aquaculture farms and related works. Its operations are based in Malaysia. The company's operating segments include: Aquaculture and agriculture; Industrial solutions; and Investment in marketable securities. It derives maximum revenue from Aquaculture and agriculture, which involves development, construction, and maintenance of aquaculture and agriculture farms and related works.
About MODD Modular Medical Inc.
Modular Medical Inc is a development stage medical device company which focuses on the design, development, and commercialization of insulin pumps using modernized technology to increase pump adoption in the diabetes marketplace. The company's products seek to serve both the type 1 and the rapidly growing, especially in terms of device adoption, type 2 diabetes markets.